中国癌症杂志2025，Vol.35Issue(9)：841-849,9.DOI:10.19401/j.cnki.1007-3639.2025.09.004
《2025版美国甲状腺学会成人分化型甲状腺癌管理指南》解读:围手术期甲状旁腺功能的评估、处理及术后TSH抑制的精准个体化管理
伍一鸣 1冯楚瑶 2高莹 1武晓泓2
作者信息
- 1. 北京大学第一医院内分泌科,北京 100034
- 2. 浙江省人民医院内分泌科,浙江 杭州 310014
- 折叠
摘要
Abstract
In recent years,the incidence of differentiated thyroid cancer(DTC)continues to rise,with increasing attention to perioperative management and postoperative thyroid-stimulating hormone(TSH)suppression therapy strategies.The American Thyroid Association(ATA)released the"2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer"in 2025,which include significant updates on perioperative parathyroid function protection and TSH suppression therapy.In terms of perioperative management,the 2025 ATA guidelines recommend intraoperative application of novel methods to identify and protect the parathyroid glands,and adoption of parathyroid hormone(PTH)-guided calcium and vitamin D supplementation protocols following total thyroidectomy.Regarding TSH suppression therapy,the 2025 ATA guidelines eliminate specific TSH target value recommendations for initial treatment,emphasizing that TSH targets should be dynamically adjusted based on patients'initial recurrence risk and treatment response to achieve individualized management and avoid overtreatment.关键词
分化型甲状腺癌/围手术期/甲状旁腺功能/促甲状腺激素抑制/个体化管理Key words
Differentiated thyroid cancer/Perioperative period/Parathyroid function/Thyroid-stimulating hormone suppression/Individualized management分类
医药卫生引用本文复制引用
伍一鸣,冯楚瑶,高莹,武晓泓..《2025版美国甲状腺学会成人分化型甲状腺癌管理指南》解读:围手术期甲状旁腺功能的评估、处理及术后TSH抑制的精准个体化管理[J].中国癌症杂志,2025,35(9):841-849,9.
